Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Research on cancer vaccines discussed by scientists at University of Nijmegen, Nijmegen Center for Molecular Life Science
March 2nd, 2007
Investigators publish new data in the report "Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines." According to recent research from Nijmegen, Netherlands, "Success of immunotherapy with dendritic cells (DC) to treat cancer is highly dependent on their interaction with and activation of antigen specific T cells. To maximize DC-T cell contact accurate delivery of the therapeutic cells into the lymph node, or efficient trafficking of DC to the lymph nodes of the patient is essential." "Since responses are seen in some patients but not in others, monitoring of the injected cells may be of major importance. Tracking...
Source: Drug Week (2007-03-02)
|
